RecruitingPhase 3NCT05980949Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyManhasset, NY · New York, NY · Stony Brook, NY · +145 more sites
RecruitingPhase 2NCT06808984Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseaseSponsor: CelgeneBuffalo, NY · Manhasset, NY · New Windsor, NY · +57 more sites
RecruitingPhase 3NCT05511363A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyManhasset, NY · New York, NY · +56 more sites
RecruitingPhase not listedNCT05847192Tau Networks in Psychotic Alzheimer's DiseaseSponsor: Northwell HealthManhasset, NY